Cases & Deals

Celgene collaborates with GlobeImmune

Clients Celgene International, Inc.

Jones Day advised Celgene International, Inc., a multinational biopharmaceutical company, in connection with its worldwide strategic collaboration with and related equity investment in GlobeImmune, Inc., a company focused on the discovery, development and commercialization of multiple product candidates based on targeted molecular immunotherapy for the treatment of cancer.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.